Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
81 participants
INTERVENTIONAL
2025-12-30
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mirror Therapy Combined With Task- vs. Impairment-oriented Rehabilitation Program
NCT06489938
Early Rehab With VR for First-time Acute Stroke
NCT05929742
Robotic Therapy Hybridized With Mirror Therapy in Stroke Rehabilitation
NCT06777654
Mirror Feedback, Augmented Task-Specific, Impairment-Oriented Therapy, Home Practice, Stroke Rehabilitation
NCT04978311
Effects of Combined Robot-assisted Therapy With Mirror Priming in Stroke Patients
NCT03917511
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-dose enhanced mirror priming group
Mirror priming
During the mirror priming process, the movement images of the participant's unaffected limb are mirrored to the affected side to provide visual feedback.
Conventional therapy
During conventional therapy, the participants typically receive interventions targeting the upper and lower limbs in addition to cognitive practice.
Low-dose enhanced mirror priming group
Mirror priming
During the mirror priming process, the movement images of the participant's unaffected limb are mirrored to the affected side to provide visual feedback.
Conventional therapy
During conventional therapy, the participants typically receive interventions targeting the upper and lower limbs in addition to cognitive practice.
Active control group
Conventional therapy
During conventional therapy, the participants typically receive interventions targeting the upper and lower limbs in addition to cognitive practice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mirror priming
During the mirror priming process, the movement images of the participant's unaffected limb are mirrored to the affected side to provide visual feedback.
Conventional therapy
During conventional therapy, the participants typically receive interventions targeting the upper and lower limbs in addition to cognitive practice.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age between 20 and 80 years
3. Baseline Fugl-Meyer Assessment Upper Extremity (FMA-UE) score \>10
4. No severe spasticity in any joints of the affected arm
5. Ability to follow the instructions
6. No participation in other studies during the study period
7. Willingness to provide informed written consent.
Exclusion Criteria
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I-Shou University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yi-chun Li
Neuro-Rehabilitation Research Laboratory (NRRL)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
E-Da Hospital
Kaohsiung City, Yanchao District, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISU-OT-Li-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.